Indias Aarti Drugs falls as US FDA issues inspectional observations - XM
| AARTIDRUGS | 431.90 0.75 0.17% |
Slightly above 61% of Aarti Drugs' investor base is looking to short. The analysis of overall sentiment of trading Aarti Drugs Limited stock suggests that many investors are alarmed at this time. Aarti Drugs' investing sentiment overview a quick insight into current market opportunities from investing in Aarti Drugs Limited. Many technical investors use Aarti Drugs Limited stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Aarti Drugs stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Aarti daily returns and investor perception about the current price of Aarti Drugs Limited as well as its diversification or hedging effects on your existing portfolios.
Aarti |
Indias Aarti Drugs falls as US FDA issues inspectional observations XM
Read at news.google.com
 |
Aarti Drugs Fundamental Analysis
We analyze Aarti Drugs' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aarti Drugs using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aarti Drugs based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Retained Earnings
Retained Earnings Comparative Analysis
Aarti Drugs is currently under evaluation in retained earnings category among its peers. Retained Earnings is a balance sheet account that refers to the portion of company income that is retained by the firm. In other words, it is a part of earnings that is not paid out as dividends or otherwise distributed to owners. Retained Earnings are calculated by adding net income to last period retained earnings and subtracting any dividends paid to owners.
Aarti Drugs Limited Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Aarti Drugs stock to make a market-neutral strategy. Peer analysis of Aarti Drugs could also be used in its relative valuation, which is a method of valuing Aarti Drugs by comparing valuation metrics with similar companies.
Peers
Aarti Drugs Related Equities
| KINGFA | Kingfa Science | 1.79 | ||||
| GATECHDVR | GACM Technologies | 1.03 | ||||
| DELTAMAGNT | Delta Manufacturing | 0.58 | ||||
| CHEMCON | Chemcon Speciality | 0.28 | ||||
| PARAGMILK | Parag Milk | 0.10 | ||||
| HEUBACHIND | Heubach Colorants | 0.16 | ||||
| RICOAUTO | Rico Auto | 0.48 | ||||
| ARVIND | Arvind | 1.18 | ||||
| COSMOFIRST | COSMO FIRST | 2.15 | ||||
| TBZ | Tribhovandas Bhimji | 2.20 |
Additional Tools for Aarti Stock Analysis
When running Aarti Drugs' price analysis, check to measure Aarti Drugs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aarti Drugs is operating at the current time. Most of Aarti Drugs' value examination focuses on studying past and present price action to predict the probability of Aarti Drugs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aarti Drugs' price. Additionally, you may evaluate how the addition of Aarti Drugs to your portfolios can decrease your overall portfolio volatility.